mr SHAWN TARRANT

H. Con. Res. 191, Continuing Resolution. Lobbied to ensure safety and access to prescription drugs. H.R. 3293, Labor Health and Human Services Appropriations bill. Lobbied to ensure safety and access to prescription drugs. H.R. 3962, Affordable Health Care for America Act and H.R. 3590, Patient Protection & Affordable Care Act (Senate). Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1548 and 1427/S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232, and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to all for the importation of unsafe prescription drugs. H.R. 1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, the Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 3293, Labor, HHS Appropriations Act. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H. Con. Res. 191, Continuing Resolution. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 3200/S. 1679, Senate Finance Committee bill. Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1427/S. 726, Promoting Innovation and Access to Life-Saving Medicines Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. H.R. 3974, Viral Hepatitis & Liver Cancer Control & Prevention Act. Lobbied for passage of legislation.

H. CON. RES 191, Continuing Resolution. Lobbied to ensure safety and access to prescription drugs. H.R. 3293, Labor Health and Human Services Appropriations bill. Lobbied to ensure safety and access to prescription drugs. NO BILL, Health Care Reform. Lobbied to gather information on potential legislation to improve the health care system and increase access to prescription drugs. H.R. 1548 and 1427/ S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232 and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R.1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, the Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 3293, Labor, HHS Appropriations Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H. Con. Res 191, Continuing Resolution. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied to ensure safety and access to prescription drugs H.R. 1298/ S. 525/ S.1232, Pharmaceutical Market Access and Drug Safety Act of 2009. Lobbied to ensure safety and access to prescription drugs. Affordable Health Choices Act. Lobbied to ensure safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied to ensure safety and access to prescription drugs. H.R. 3200/ S.1679/, Senate Finance Committee bill. Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1427/ S. 726, Promoting Innovation and Access to Life-Saving Medicine Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety and data exclusivity.

NO BILL, Health Care Reform. Lobbied to gather information on potential legislation to improve the health care system and increase access to prescription drugs. H.R.1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1548, Pathway for Biosimilars Act. Lobbied Members of congress in support of an FDA pathway for biosimilar products, patient safety and data exclusivity. H.R.1427/ S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232 and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied to ensure safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied to ensure safety and access to prescription drugs. HELP Health Reform Draft Bill. Lobbied Members of Congress to ensure safety and access to prescription drugs. Comprehensive Health Reform Draft Bill. Lobbied Members of Congress to ensure safety and access to prescription drugs. Affordable Health Choices Act. Lobbied to ensure safety and access to prescription drugs.

NO BILL, Health Care Reform. Lobbied to gather information on potential legislation to improve the health care system and increase access to prescription drugs. H.R.1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1548, Pathway for Biosimilars Act. Lobbied Members of congress in support of an FDA pathway for biosimilar products, patient safety and data exclusivity. H.R.1427/ S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232 and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied to ensure safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied to ensure safety and access to prescription drugs. HELP Health Reform Draft Bill. Lobbied Members of Congress to ensure safety and access to prescription drugs. Comprehensive Health Reform Draft Bill. Lobbied Members of Congress to ensure safety and access to prescription drugs. Affordable Health Choices Act. Lobbied to ensure safety and access to prescription drugs.

H. Con. Res. 191, Continuing Resolution. Lobbied to ensure safety and access to prescription drugs. H.R. 3293, Labor Health and Human Services Appropriations bill. Lobbied to ensure safety and access to prescription drugs. H.R. 3962, Affordable Health Care for America Act and H.R. 3590, Patient Protection & Affordable Care Act (Senate). Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1548 and 1427/S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232, and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to all for the importation of unsafe prescription drugs. H.R. 1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, the Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 3293, Labor, HHS Appropriations Act. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H. Con. Res. 191, Continuing Resolution. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 3200/S. 1679, Senate Finance Committee bill. Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1427/S. 726, Promoting Innovation and Access to Life-Saving Medicines Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. H.R. 3974, Viral Hepatitis & Liver Cancer Control & Prevention Act. Lobbied for passage of legislation.

H. Con. Res. 191, Continuing Resolution. Lobbied to ensure safety and access to prescription drugs. H.R. 3293, Labor Health and Human Services Appropriations bill. Lobbied to ensure safety and access to prescription drugs. H.R. 3962, Affordable Health Care for America Act and H.R. 3590, Patient Protection & Affordable Care Act (Senate). Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1548 and 1427/S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232, and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to all for the importation of unsafe prescription drugs. H.R. 1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, the Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 3293, Labor, HHS Appropriations Act. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H. Con. Res. 191, Continuing Resolution. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 3200/S. 1679, Senate Finance Committee bill. Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1427/S. 726, Promoting Innovation and Access to Life-Saving Medicines Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. H.R. 3974, Viral Hepatitis & Liver Cancer Control & Prevention Act. Lobbied for passage of legislation.

H. CON. RES 191, Continuing Resolution. Lobbied to ensure safety and access to prescription drugs. H.R. 3293, Labor Health and Human Services Appropriations bill. Lobbied to ensure safety and access to prescription drugs. NO BILL, Health Care Reform. Lobbied to gather information on potential legislation to improve the health care system and increase access to prescription drugs. H.R. 1548 and 1427/ S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232 and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R.1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, the Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 3293, Labor, HHS Appropriations Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H. Con. Res 191, Continuing Resolution. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied to ensure safety and access to prescription drugs H.R. 1298/ S. 525/ S.1232, Pharmaceutical Market Access and Drug Safety Act of 2009. Lobbied to ensure safety and access to prescription drugs. Affordable Health Choices Act. Lobbied to ensure safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied to ensure safety and access to prescription drugs. H.R. 3200/ S.1679/, Senate Finance Committee bill. Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1427/ S. 726, Promoting Innovation and Access to Life-Saving Medicine Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety and data exclusivity.

NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D. H.R. 1458/S. 565, Comprehensive Immunosuppresive Drug Coverage for Kidney Transplant Patients Act of 2007. Lobbied for passage of bills. S. 547, Drug Rebate Equalization Act of 2009. Lobbied against extending the Medicaid rebate to managed care organizations. H.R. 684/S. 330, Medicare Prescription Drug Savings and Choice Act of 2009. Lobbied against establishing a government sponsored fall-back plan in Medicare Part D. H.R. 574/S. 254, Medicare Home Infusion Therapy Coverage Act of 2009. Lobbied for passage of bills. S. 301, Physician Payments Sunshine Act of 2009. Lobbied to ensure access to prescription drugs. H.R. 1616, Early Treatment of HIV/AIDS. Lobbied in support of early treatment of HIV/AIDS.

NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D. H.R.1458/ S.565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007.Lobbied for passage of bills. S. 547, Drug Rebate Equalization Act of 2009. Lobbied against extending the Medicaid rebate to managed care organizations H.R.1458/ S.565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007. Lobbied for passage of bills. H.R. 684/ S. 330, Medicare Prescription Drug Savings and Choice Act of 2009. Lobbied against establishing a government sponsored fall-back plan in Medicare Part D. H.R. 574/ S. 254, Medicare Home Infusion Therapy Coverage Act of 2009. Lobbied for passage of bills. S. 301, Physician Payments Sunshine Act of 2009. Lobbied to ensure access to prescription drugs. NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D. H.R. 1616, Early Treatment of HIV/AIDS. Lobbied in support of early treatment of HIV/AIDS.

NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D. H.R. 1458/S. 565, Comprehensive Immunosuppresive Drug Coverage for Kidney Transplant Patients Act of 2007. Lobbied for passage of bills. S. 547, Drug Rebate Equalization Act of 2009. Lobbied against extending the Medicaid rebate to managed care organizations. H.R. 684/S. 330, Medicare Prescription Drug Savings and Choice Act of 2009. Lobbied against establishing a government sponsored fall-back plan in Medicare Part D. H.R. 574/S. 254, Medicare Home Infusion Therapy Coverage Act of 2009. Lobbied for passage of bills. S. 301, Physician Payments Sunshine Act of 2009. Lobbied to ensure access to prescription drugs. H.R. 1616, Early Treatment of HIV/AIDS. Lobbied in support of early treatment of HIV/AIDS.

H. CON. RES 191, Continuing Resolution. Lobbied to ensure safety and access to prescription drugs. H.R. 3293, Labor Health and Human Services Appropriations bill. Lobbied to ensure safety and access to prescription drugs. NO BILL, Health Care Reform. Lobbied to gather information on potential legislation to improve the health care system and increase access to prescription drugs. H.R. 1548 and 1427/ S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232 and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R.1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, the Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 3293, Labor, HHS Appropriations Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H. Con. Res 191, Continuing Resolution. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied to ensure safety and access to prescription drugs H.R. 1298/ S. 525/ S.1232, Pharmaceutical Market Access and Drug Safety Act of 2009. Lobbied to ensure safety and access to prescription drugs. Affordable Health Choices Act. Lobbied to ensure safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied to ensure safety and access to prescription drugs. H.R. 3200/ S.1679/, Senate Finance Committee bill. Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1427/ S. 726, Promoting Innovation and Access to Life-Saving Medicine Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety and data exclusivity.

H. Con. Res. 191, Continuing Resolution. Lobbied to ensure safety and access to prescription drugs. H.R. 3293, Labor Health and Human Services Appropriations bill. Lobbied to ensure safety and access to prescription drugs. H.R. 3962, Affordable Health Care for America Act and H.R. 3590, Patient Protection & Affordable Care Act (Senate). Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1548 and 1427/S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232, and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to all for the importation of unsafe prescription drugs. H.R. 1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, the Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 3293, Labor, HHS Appropriations Act. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H. Con. Res. 191, Continuing Resolution. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 3200/S. 1679, Senate Finance Committee bill. Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1427/S. 726, Promoting Innovation and Access to Life-Saving Medicines Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. H.R. 3974, Viral Hepatitis & Liver Cancer Control & Prevention Act. Lobbied for passage of legislation.

NO BILL, Health Care Reform. Lobbied to gather information on potential legislation to improve the health care system and increase access to prescription drugs. H.R.1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1548, Pathway for Biosimilars Act. Lobbied Members of congress in support of an FDA pathway for biosimilar products, patient safety and data exclusivity. H.R.1427/ S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232 and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied to ensure safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied to ensure safety and access to prescription drugs. HELP Health Reform Draft Bill. Lobbied Members of Congress to ensure safety and access to prescription drugs. Comprehensive Health Reform Draft Bill. Lobbied Members of Congress to ensure safety and access to prescription drugs. Affordable Health Choices Act. Lobbied to ensure safety and access to prescription drugs.

H. Con. Res. 191, Continuing Resolution. Lobbied to ensure safety and access to prescription drugs. H.R. 3293, Labor Health and Human Services Appropriations bill. Lobbied to ensure safety and access to prescription drugs. H.R. 3962, Affordable Health Care for America Act and H.R. 3590, Patient Protection & Affordable Care Act (Senate). Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1548 and 1427/S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232, and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to all for the importation of unsafe prescription drugs. H.R. 1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, the Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 3293, Labor, HHS Appropriations Act. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H. Con. Res. 191, Continuing Resolution. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 3200/S. 1679, Senate Finance Committee bill. Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1427/S. 726, Promoting Innovation and Access to Life-Saving Medicines Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. H.R. 3974, Viral Hepatitis & Liver Cancer Control & Prevention Act. Lobbied for passage of legislation.

NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D. H.R. 1616, Early Treatment of HIV/AIDS. Lobbied members of Congress in support of early treatment of HIV/AIDS. H.R. 684 and S. 330, Medicare Prescription Drug Savings and Choice Act. Lobbied against establishing a government sponsored fall-back plan in Medicare Part D. H.R. 574 and S. 254, Medicare Home Infusion Therapy Coverage Act.Lobbied for passage of the bill. H.R.1458/ S.565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007. Lobbied for passage of bills. S. 301, Physician Payments Sunshine Act of 2009. Lobbied to ensure access to prescription drugs. S. 547, Drug Rebate Equalization Act. Lobbied against extending the Medicaid rebate to managed care organizations.

NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D. H.R. 1458/S. 565, Comprehensive Immunosuppresive Drug Coverage for Kidney Transplant Patients Act of 2007. Lobbied for passage of bills. S. 547, Drug Rebate Equalization Act of 2009. Lobbied against extending the Medicaid rebate to managed care organizations. H.R. 684/S. 330, Medicare Prescription Drug Savings and Choice Act of 2009. Lobbied against establishing a government sponsored fall-back plan in Medicare Part D. H.R. 574/S. 254, Medicare Home Infusion Therapy Coverage Act of 2009. Lobbied for passage of bills. S. 301, Physician Payments Sunshine Act of 2009. Lobbied to ensure access to prescription drugs. H.R. 1616, Early Treatment of HIV/AIDS. Lobbied in support of early treatment of HIV/AIDS.

NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D. H.R. 1458/S. 565, Comprehensive Immunosuppresive Drug Coverage for Kidney Transplant Patients Act of 2007. Lobbied for passage of bills. S. 547, Drug Rebate Equalization Act of 2009. Lobbied against extending the Medicaid rebate to managed care organizations. H.R. 684/S. 330, Medicare Prescription Drug Savings and Choice Act of 2009. Lobbied against establishing a government sponsored fall-back plan in Medicare Part D. H.R. 574/S. 254, Medicare Home Infusion Therapy Coverage Act of 2009. Lobbied for passage of bills. S. 301, Physician Payments Sunshine Act of 2009. Lobbied to ensure access to prescription drugs. H.R. 1616, Early Treatment of HIV/AIDS. Lobbied in support of early treatment of HIV/AIDS.

NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D. H.R.1458/ S.565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007.Lobbied for passage of bills. S. 547, Drug Rebate Equalization Act of 2009. Lobbied against extending the Medicaid rebate to managed care organizations H.R.1458/ S.565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007. Lobbied for passage of bills. H.R. 684/ S. 330, Medicare Prescription Drug Savings and Choice Act of 2009. Lobbied against establishing a government sponsored fall-back plan in Medicare Part D. H.R. 574/ S. 254, Medicare Home Infusion Therapy Coverage Act of 2009. Lobbied for passage of bills. S. 301, Physician Payments Sunshine Act of 2009. Lobbied to ensure access to prescription drugs. NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D. H.R. 1616, Early Treatment of HIV/AIDS. Lobbied in support of early treatment of HIV/AIDS.

NO BILL, Health Care Reform. Lobbied to gather information on potential legislation to improve the health care system and increase access to prescription drugs. H.R.1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1548, Pathway for Biosimilars Act. Lobbied Members of congress in support of an FDA pathway for biosimilar products, patient safety and data exclusivity. H.R.1427/ S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232 and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied to ensure safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied to ensure safety and access to prescription drugs. HELP Health Reform Draft Bill. Lobbied Members of Congress to ensure safety and access to prescription drugs. Comprehensive Health Reform Draft Bill. Lobbied Members of Congress to ensure safety and access to prescription drugs. Affordable Health Choices Act. Lobbied to ensure safety and access to prescription drugs.

H. Con. Res. 191, Continuing Resolution. Lobbied to ensure safety and access to prescription drugs. H.R. 3293, Labor Health and Human Services Appropriations bill. Lobbied to ensure safety and access to prescription drugs. H.R. 3962, Affordable Health Care for America Act and H.R. 3590, Patient Protection & Affordable Care Act (Senate). Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1548 and 1427/S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232, and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to all for the importation of unsafe prescription drugs. H.R. 1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, the Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 3293, Labor, HHS Appropriations Act. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H. Con. Res. 191, Continuing Resolution. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 3200/S. 1679, Senate Finance Committee bill. Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1427/S. 726, Promoting Innovation and Access to Life-Saving Medicines Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. H.R. 3974, Viral Hepatitis & Liver Cancer Control & Prevention Act. Lobbied for passage of legislation.

H. Con. Res. 191, Continuing Resolution. Lobbied to ensure safety and access to prescription drugs. H.R. 3293, Labor Health and Human Services Appropriations bill. Lobbied to ensure safety and access to prescription drugs. H.R. 3962, Affordable Health Care for America Act and H.R. 3590, Patient Protection & Affordable Care Act (Senate). Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1548 and 1427/S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232, and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to all for the importation of unsafe prescription drugs. H.R. 1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, the Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 3293, Labor, HHS Appropriations Act. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H. Con. Res. 191, Continuing Resolution. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 3200/S. 1679, Senate Finance Committee bill. Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1427/S. 726, Promoting Innovation and Access to Life-Saving Medicines Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. H.R. 3974, Viral Hepatitis & Liver Cancer Control & Prevention Act. Lobbied for passage of legislation.

H. CON. RES 191, Continuing Resolution. Lobbied to ensure safety and access to prescription drugs. H.R. 3293, Labor Health and Human Services Appropriations bill. Lobbied to ensure safety and access to prescription drugs. NO BILL, Health Care Reform. Lobbied to gather information on potential legislation to improve the health care system and increase access to prescription drugs. H.R. 1548 and 1427/ S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232 and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R.1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, the Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 3293, Labor, HHS Appropriations Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H. Con. Res 191, Continuing Resolution. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied to ensure safety and access to prescription drugs H.R. 1298/ S. 525/ S.1232, Pharmaceutical Market Access and Drug Safety Act of 2009. Lobbied to ensure safety and access to prescription drugs. Affordable Health Choices Act. Lobbied to ensure safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied to ensure safety and access to prescription drugs. H.R. 3200/ S.1679/, Senate Finance Committee bill. Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1427/ S. 726, Promoting Innovation and Access to Life-Saving Medicine Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety and data exclusivity.

H. Con. Res. 191, Continuing Resolution. Lobbied to ensure safety and access to prescription drugs. H.R. 3293, Labor Health and Human Services Appropriations bill. Lobbied to ensure safety and access to prescription drugs. H.R. 3962, Affordable Health Care for America Act and H.R. 3590, Patient Protection & Affordable Care Act (Senate). Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1548 and 1427/S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232, and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to all for the importation of unsafe prescription drugs. H.R. 1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, the Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 3293, Labor, HHS Appropriations Act. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H. Con. Res. 191, Continuing Resolution. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 3200/S. 1679, Senate Finance Committee bill. Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1427/S. 726, Promoting Innovation and Access to Life-Saving Medicines Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. H.R. 3974, Viral Hepatitis & Liver Cancer Control & Prevention Act. Lobbied for passage of legislation.

H. Con. Res. 191, Continuing Resolution. Lobbied to ensure safety and access to prescription drugs. H.R. 3293, Labor Health and Human Services Appropriations bill. Lobbied to ensure safety and access to prescription drugs. H.R. 3962, Affordable Health Care for America Act and H.R. 3590, Patient Protection & Affordable Care Act (Senate). Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1548 and 1427/S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232, and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to all for the importation of unsafe prescription drugs. H.R. 1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, the Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 3293, Labor, HHS Appropriations Act. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H. Con. Res. 191, Continuing Resolution. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 3200/S. 1679, Senate Finance Committee bill. Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1427/S. 726, Promoting Innovation and Access to Life-Saving Medicines Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. H.R. 3974, Viral Hepatitis & Liver Cancer Control & Prevention Act. Lobbied for passage of legislation.

H. CON. RES 191, Continuing Resolution. Lobbied to ensure safety and access to prescription drugs. H.R. 3293, Labor Health and Human Services Appropriations bill. Lobbied to ensure safety and access to prescription drugs. NO BILL, Health Care Reform. Lobbied to gather information on potential legislation to improve the health care system and increase access to prescription drugs. H.R. 1548 and 1427/ S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232 and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R.1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, the Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 3293, Labor, HHS Appropriations Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H. Con. Res 191, Continuing Resolution. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied to ensure safety and access to prescription drugs H.R. 1298/ S. 525/ S.1232, Pharmaceutical Market Access and Drug Safety Act of 2009. Lobbied to ensure safety and access to prescription drugs. Affordable Health Choices Act. Lobbied to ensure safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied to ensure safety and access to prescription drugs. H.R. 3200/ S.1679/, Senate Finance Committee bill. Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1427/ S. 726, Promoting Innovation and Access to Life-Saving Medicine Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety and data exclusivity.

H. Con. Res. 191, Continuing Resolution. Lobbied to ensure safety and access to prescription drugs. H.R. 3293, Labor Health and Human Services Appropriations bill. Lobbied to ensure safety and access to prescription drugs. H.R. 3962, Affordable Health Care for America Act and H.R. 3590, Patient Protection & Affordable Care Act (Senate). Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1548 and 1427/S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232, and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to all for the importation of unsafe prescription drugs. H.R. 1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, the Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 3293, Labor, HHS Appropriations Act. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H. Con. Res. 191, Continuing Resolution. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 3200/S. 1679, Senate Finance Committee bill. Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1427/S. 726, Promoting Innovation and Access to Life-Saving Medicines Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. H.R. 3974, Viral Hepatitis & Liver Cancer Control & Prevention Act. Lobbied for passage of legislation.

H. CON. RES 191, Continuing Resolution. Lobbied to ensure safety and access to prescription drugs. H.R. 3293, Labor Health and Human Services Appropriations bill. Lobbied to ensure safety and access to prescription drugs. NO BILL, Health Care Reform. Lobbied to gather information on potential legislation to improve the health care system and increase access to prescription drugs. H.R. 1548 and 1427/ S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232 and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R.1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, the Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 3293, Labor, HHS Appropriations Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H. Con. Res 191, Continuing Resolution. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied to ensure safety and access to prescription drugs H.R. 1298/ S. 525/ S.1232, Pharmaceutical Market Access and Drug Safety Act of 2009. Lobbied to ensure safety and access to prescription drugs. Affordable Health Choices Act. Lobbied to ensure safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied to ensure safety and access to prescription drugs. H.R. 3200/ S.1679/, Senate Finance Committee bill. Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1427/ S. 726, Promoting Innovation and Access to Life-Saving Medicine Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety and data exclusivity.

H. Con. Res. 191, Continuing Resolution. Lobbied to ensure safety and access to prescription drugs. H.R. 3293, Labor Health and Human Services Appropriations bill. Lobbied to ensure safety and access to prescription drugs. H.R. 3962, Affordable Health Care for America Act and H.R. 3590, Patient Protection & Affordable Care Act (Senate). Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1548 and 1427/S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232, and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to all for the importation of unsafe prescription drugs. H.R. 1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, the Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 3293, Labor, HHS Appropriations Act. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H. Con. Res. 191, Continuing Resolution. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 3200/S. 1679, Senate Finance Committee bill. Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1427/S. 726, Promoting Innovation and Access to Life-Saving Medicines Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. H.R. 3974, Viral Hepatitis & Liver Cancer Control & Prevention Act. Lobbied for passage of legislation.

H. Con. Res. 191, Continuing Resolution. Lobbied to ensure safety and access to prescription drugs. H.R. 3293, Labor Health and Human Services Appropriations bill. Lobbied to ensure safety and access to prescription drugs. H.R. 3962, Affordable Health Care for America Act and H.R. 3590, Patient Protection & Affordable Care Act (Senate). Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1548 and 1427/S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232, and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to all for the importation of unsafe prescription drugs. H.R. 1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, the Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 3293, Labor, HHS Appropriations Act. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H. Con. Res. 191, Continuing Resolution. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 3200/S. 1679, Senate Finance Committee bill. Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1427/S. 726, Promoting Innovation and Access to Life-Saving Medicines Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. H.R. 3974, Viral Hepatitis & Liver Cancer Control & Prevention Act. Lobbied for passage of legislation.

H. Con. Res. 191, Continuing Resolution. Lobbied to ensure safety and access to prescription drugs. H.R. 3293, Labor Health and Human Services Appropriations bill. Lobbied to ensure safety and access to prescription drugs. H.R. 3962, Affordable Health Care for America Act and H.R. 3590, Patient Protection & Affordable Care Act (Senate). Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1548 and 1427/S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232, and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to all for the importation of unsafe prescription drugs. H.R. 1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, the Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 3293, Labor, HHS Appropriations Act. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H. Con. Res. 191, Continuing Resolution. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 3200/S. 1679, Senate Finance Committee bill. Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1427/S. 726, Promoting Innovation and Access to Life-Saving Medicines Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. H.R. 3974, Viral Hepatitis & Liver Cancer Control & Prevention Act. Lobbied for passage of legislation.

NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D. H.R. 1616, Early Treatment of HIV/AIDS. Lobbied members of Congress in support of early treatment of HIV/AIDS. H.R. 684 and S. 330, Medicare Prescription Drug Savings and Choice Act. Lobbied against establishing a government sponsored fall-back plan in Medicare Part D. H.R. 574 and S. 254, Medicare Home Infusion Therapy Coverage Act.Lobbied for passage of the bill. H.R.1458/ S.565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007. Lobbied for passage of bills. S. 301, Physician Payments Sunshine Act of 2009. Lobbied to ensure access to prescription drugs. S. 547, Drug Rebate Equalization Act. Lobbied against extending the Medicaid rebate to managed care organizations.

NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D. H.R. 1458/S. 565, Comprehensive Immunosuppresive Drug Coverage for Kidney Transplant Patients Act of 2007. Lobbied for passage of bills. S. 547, Drug Rebate Equalization Act of 2009. Lobbied against extending the Medicaid rebate to managed care organizations. H.R. 684/S. 330, Medicare Prescription Drug Savings and Choice Act of 2009. Lobbied against establishing a government sponsored fall-back plan in Medicare Part D. H.R. 574/S. 254, Medicare Home Infusion Therapy Coverage Act of 2009. Lobbied for passage of bills. S. 301, Physician Payments Sunshine Act of 2009. Lobbied to ensure access to prescription drugs. H.R. 1616, Early Treatment of HIV/AIDS. Lobbied in support of early treatment of HIV/AIDS.

NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D. H.R.1458/ S.565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007.Lobbied for passage of bills. S. 547, Drug Rebate Equalization Act of 2009. Lobbied against extending the Medicaid rebate to managed care organizations H.R.1458/ S.565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007. Lobbied for passage of bills. H.R. 684/ S. 330, Medicare Prescription Drug Savings and Choice Act of 2009. Lobbied against establishing a government sponsored fall-back plan in Medicare Part D. H.R. 574/ S. 254, Medicare Home Infusion Therapy Coverage Act of 2009. Lobbied for passage of bills. S. 301, Physician Payments Sunshine Act of 2009. Lobbied to ensure access to prescription drugs. NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D. H.R. 1616, Early Treatment of HIV/AIDS. Lobbied in support of early treatment of HIV/AIDS.

NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D. H.R. 1458/S. 565, Comprehensive Immunosuppresive Drug Coverage for Kidney Transplant Patients Act of 2007. Lobbied for passage of bills. S. 547, Drug Rebate Equalization Act of 2009. Lobbied against extending the Medicaid rebate to managed care organizations. H.R. 684/S. 330, Medicare Prescription Drug Savings and Choice Act of 2009. Lobbied against establishing a government sponsored fall-back plan in Medicare Part D. H.R. 574/S. 254, Medicare Home Infusion Therapy Coverage Act of 2009. Lobbied for passage of bills. S. 301, Physician Payments Sunshine Act of 2009. Lobbied to ensure access to prescription drugs. H.R. 1616, Early Treatment of HIV/AIDS. Lobbied in support of early treatment of HIV/AIDS.

NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D. H.R. 1458/S. 565, Comprehensive Immunosuppresive Drug Coverage for Kidney Transplant Patients Act of 2007. Lobbied for passage of bills. S. 547, Drug Rebate Equalization Act of 2009. Lobbied against extending the Medicaid rebate to managed care organizations. H.R. 684/S. 330, Medicare Prescription Drug Savings and Choice Act of 2009. Lobbied against establishing a government sponsored fall-back plan in Medicare Part D. H.R. 574/S. 254, Medicare Home Infusion Therapy Coverage Act of 2009. Lobbied for passage of bills. S. 301, Physician Payments Sunshine Act of 2009. Lobbied to ensure access to prescription drugs. H.R. 1616, Early Treatment of HIV/AIDS. Lobbied in support of early treatment of HIV/AIDS.

NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D. H.R.1458/ S.565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007.Lobbied for passage of bills. S. 547, Drug Rebate Equalization Act of 2009. Lobbied against extending the Medicaid rebate to managed care organizations H.R.1458/ S.565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007. Lobbied for passage of bills. H.R. 684/ S. 330, Medicare Prescription Drug Savings and Choice Act of 2009. Lobbied against establishing a government sponsored fall-back plan in Medicare Part D. H.R. 574/ S. 254, Medicare Home Infusion Therapy Coverage Act of 2009. Lobbied for passage of bills. S. 301, Physician Payments Sunshine Act of 2009. Lobbied to ensure access to prescription drugs. NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D. H.R. 1616, Early Treatment of HIV/AIDS. Lobbied in support of early treatment of HIV/AIDS.

NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D. H.R. 1616, Early Treatment of HIV/AIDS. Lobbied members of Congress in support of early treatment of HIV/AIDS. H.R. 684 and S. 330, Medicare Prescription Drug Savings and Choice Act. Lobbied against establishing a government sponsored fall-back plan in Medicare Part D. H.R. 574 and S. 254, Medicare Home Infusion Therapy Coverage Act.Lobbied for passage of the bill. H.R.1458/ S.565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007. Lobbied for passage of bills. S. 301, Physician Payments Sunshine Act of 2009. Lobbied to ensure access to prescription drugs. S. 547, Drug Rebate Equalization Act. Lobbied against extending the Medicaid rebate to managed care organizations.

NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D. H.R. 1458/S. 565, Comprehensive Immunosuppresive Drug Coverage for Kidney Transplant Patients Act of 2007. Lobbied for passage of bills. S. 547, Drug Rebate Equalization Act of 2009. Lobbied against extending the Medicaid rebate to managed care organizations. H.R. 684/S. 330, Medicare Prescription Drug Savings and Choice Act of 2009. Lobbied against establishing a government sponsored fall-back plan in Medicare Part D. H.R. 574/S. 254, Medicare Home Infusion Therapy Coverage Act of 2009. Lobbied for passage of bills. S. 301, Physician Payments Sunshine Act of 2009. Lobbied to ensure access to prescription drugs. H.R. 1616, Early Treatment of HIV/AIDS. Lobbied in support of early treatment of HIV/AIDS.

NO BILL, Health Care Reform. Lobbied to gather information on potential legislation to improve the health care system and increase access to prescription drugs. H.R.1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1548, Pathway for Biosimilars Act. Lobbied Members of congress in support of an FDA pathway for biosimilar products, patient safety and data exclusivity. H.R.1427/ S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232 and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied to ensure safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied to ensure safety and access to prescription drugs. HELP Health Reform Draft Bill. Lobbied Members of Congress to ensure safety and access to prescription drugs. Comprehensive Health Reform Draft Bill. Lobbied Members of Congress to ensure safety and access to prescription drugs. Affordable Health Choices Act. Lobbied to ensure safety and access to prescription drugs.

H. CON. RES 191, Continuing Resolution. Lobbied to ensure safety and access to prescription drugs. H.R. 3293, Labor Health and Human Services Appropriations bill. Lobbied to ensure safety and access to prescription drugs. NO BILL, Health Care Reform. Lobbied to gather information on potential legislation to improve the health care system and increase access to prescription drugs. H.R. 1548 and 1427/ S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232 and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R.1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, the Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 3293, Labor, HHS Appropriations Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H. Con. Res 191, Continuing Resolution. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied to ensure safety and access to prescription drugs H.R. 1298/ S. 525/ S.1232, Pharmaceutical Market Access and Drug Safety Act of 2009. Lobbied to ensure safety and access to prescription drugs. Affordable Health Choices Act. Lobbied to ensure safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied to ensure safety and access to prescription drugs. H.R. 3200/ S.1679/, Senate Finance Committee bill. Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1427/ S. 726, Promoting Innovation and Access to Life-Saving Medicine Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety and data exclusivity.

H. Con. Res. 191, Continuing Resolution. Lobbied to ensure safety and access to prescription drugs. H.R. 3293, Labor Health and Human Services Appropriations bill. Lobbied to ensure safety and access to prescription drugs. H.R. 3962, Affordable Health Care for America Act and H.R. 3590, Patient Protection & Affordable Care Act (Senate). Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1548 and 1427/S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232, and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to all for the importation of unsafe prescription drugs. H.R. 1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, the Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 3293, Labor, HHS Appropriations Act. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H. Con. Res. 191, Continuing Resolution. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 3200/S. 1679, Senate Finance Committee bill. Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1427/S. 726, Promoting Innovation and Access to Life-Saving Medicines Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. H.R. 3974, Viral Hepatitis & Liver Cancer Control & Prevention Act. Lobbied for passage of legislation.

H. Con. Res. 191, Continuing Resolution. Lobbied to ensure safety and access to prescription drugs. H.R. 3293, Labor Health and Human Services Appropriations bill. Lobbied to ensure safety and access to prescription drugs. H.R. 3962, Affordable Health Care for America Act and H.R. 3590, Patient Protection & Affordable Care Act (Senate). Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1548 and 1427/S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232, and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to all for the importation of unsafe prescription drugs. H.R. 1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, the Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 3293, Labor, HHS Appropriations Act. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H. Con. Res. 191, Continuing Resolution. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 3200/S. 1679, Senate Finance Committee bill. Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1427/S. 726, Promoting Innovation and Access to Life-Saving Medicines Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. H.R. 3974, Viral Hepatitis & Liver Cancer Control & Prevention Act. Lobbied for passage of legislation.

H. Con. Res. 191, Continuing Resolution. Lobbied to ensure safety and access to prescription drugs. H.R. 3293, Labor Health and Human Services Appropriations bill. Lobbied to ensure safety and access to prescription drugs. H.R. 3962, Affordable Health Care for America Act and H.R. 3590, Patient Protection & Affordable Care Act (Senate). Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1548 and 1427/S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232, and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to all for the importation of unsafe prescription drugs. H.R. 1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, the Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 3293, Labor, HHS Appropriations Act. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H. Con. Res. 191, Continuing Resolution. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 3200/S. 1679, Senate Finance Committee bill. Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1427/S. 726, Promoting Innovation and Access to Life-Saving Medicines Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. H.R. 3974, Viral Hepatitis & Liver Cancer Control & Prevention Act. Lobbied for passage of legislation.

NO BILL, Health Care Reform. Lobbied to gather information on potential legislation to improve the health care system and increase access to prescription drugs. H.R.1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1548, Pathway for Biosimilars Act. Lobbied Members of congress in support of an FDA pathway for biosimilar products, patient safety and data exclusivity. H.R.1427/ S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232 and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied to ensure safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied to ensure safety and access to prescription drugs. HELP Health Reform Draft Bill. Lobbied Members of Congress to ensure safety and access to prescription drugs. Comprehensive Health Reform Draft Bill. Lobbied Members of Congress to ensure safety and access to prescription drugs. Affordable Health Choices Act. Lobbied to ensure safety and access to prescription drugs.

H. CON. RES 191, Continuing Resolution. Lobbied to ensure safety and access to prescription drugs. H.R. 3293, Labor Health and Human Services Appropriations bill. Lobbied to ensure safety and access to prescription drugs. NO BILL, Health Care Reform. Lobbied to gather information on potential legislation to improve the health care system and increase access to prescription drugs. H.R. 1548 and 1427/ S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232 and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R.1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, the Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 3293, Labor, HHS Appropriations Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H. Con. Res 191, Continuing Resolution. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied to ensure safety and access to prescription drugs H.R. 1298/ S. 525/ S.1232, Pharmaceutical Market Access and Drug Safety Act of 2009. Lobbied to ensure safety and access to prescription drugs. Affordable Health Choices Act. Lobbied to ensure safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied to ensure safety and access to prescription drugs. H.R. 3200/ S.1679/, Senate Finance Committee bill. Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1427/ S. 726, Promoting Innovation and Access to Life-Saving Medicine Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety and data exclusivity.

H. Con. Res. 191, Continuing Resolution. Lobbied to ensure safety and access to prescription drugs. H.R. 3293, Labor Health and Human Services Appropriations bill. Lobbied to ensure safety and access to prescription drugs. H.R. 3962, Affordable Health Care for America Act and H.R. 3590, Patient Protection & Affordable Care Act (Senate). Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1548 and 1427/S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232, and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to all for the importation of unsafe prescription drugs. H.R. 1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, the Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 3293, Labor, HHS Appropriations Act. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H. Con. Res. 191, Continuing Resolution. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 3200/S. 1679, Senate Finance Committee bill. Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1427/S. 726, Promoting Innovation and Access to Life-Saving Medicines Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. H.R. 3974, Viral Hepatitis & Liver Cancer Control & Prevention Act. Lobbied for passage of legislation.

H. Con. Res. 191, Continuing Resolution. Lobbied to ensure safety and access to prescription drugs. H.R. 3293, Labor Health and Human Services Appropriations bill. Lobbied to ensure safety and access to prescription drugs. H.R. 3962, Affordable Health Care for America Act and H.R. 3590, Patient Protection & Affordable Care Act (Senate). Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1548 and 1427/S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232, and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to all for the importation of unsafe prescription drugs. H.R. 1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, the Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 3293, Labor, HHS Appropriations Act. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H. Con. Res. 191, Continuing Resolution. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 3200/S. 1679, Senate Finance Committee bill. Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1427/S. 726, Promoting Innovation and Access to Life-Saving Medicines Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. H.R. 3974, Viral Hepatitis & Liver Cancer Control & Prevention Act. Lobbied for passage of legislation.

H. Con. Res. 191, Continuing Resolution. Lobbied to ensure safety and access to prescription drugs. H.R. 3293, Labor Health and Human Services Appropriations bill. Lobbied to ensure safety and access to prescription drugs. H.R. 3962, Affordable Health Care for America Act and H.R. 3590, Patient Protection & Affordable Care Act (Senate). Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1548 and 1427/S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232, and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to all for the importation of unsafe prescription drugs. H.R. 1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, the Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 3293, Labor, HHS Appropriations Act. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H. Con. Res. 191, Continuing Resolution. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 3200/S. 1679, Senate Finance Committee bill. Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1427/S. 726, Promoting Innovation and Access to Life-Saving Medicines Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. H.R. 3974, Viral Hepatitis & Liver Cancer Control & Prevention Act. Lobbied for passage of legislation.

H. CON. RES 191, Continuing Resolution. Lobbied to ensure safety and access to prescription drugs. H.R. 3293, Labor Health and Human Services Appropriations bill. Lobbied to ensure safety and access to prescription drugs. NO BILL, Health Care Reform. Lobbied to gather information on potential legislation to improve the health care system and increase access to prescription drugs. H.R. 1548 and 1427/ S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232 and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R.1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, the Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 3293, Labor, HHS Appropriations Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H. Con. Res 191, Continuing Resolution. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied to ensure safety and access to prescription drugs H.R. 1298/ S. 525/ S.1232, Pharmaceutical Market Access and Drug Safety Act of 2009. Lobbied to ensure safety and access to prescription drugs. Affordable Health Choices Act. Lobbied to ensure safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied to ensure safety and access to prescription drugs. H.R. 3200/ S.1679/, Senate Finance Committee bill. Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1427/ S. 726, Promoting Innovation and Access to Life-Saving Medicine Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety and data exclusivity.

NO BILL, Health Care Reform. Lobbied to gather information on potential legislation to improve the health care system and increase access to prescription drugs. H.R.1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1548, Pathway for Biosimilars Act. Lobbied Members of congress in support of an FDA pathway for biosimilar products, patient safety and data exclusivity. H.R.1427/ S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232 and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied to ensure safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied to ensure safety and access to prescription drugs. HELP Health Reform Draft Bill. Lobbied Members of Congress to ensure safety and access to prescription drugs. Comprehensive Health Reform Draft Bill. Lobbied Members of Congress to ensure safety and access to prescription drugs. Affordable Health Choices Act. Lobbied to ensure safety and access to prescription drugs.

H. Con. Res. 191, Continuing Resolution. Lobbied to ensure safety and access to prescription drugs. H.R. 3293, Labor Health and Human Services Appropriations bill. Lobbied to ensure safety and access to prescription drugs. H.R. 3962, Affordable Health Care for America Act and H.R. 3590, Patient Protection & Affordable Care Act (Senate). Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1548 and 1427/S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232, and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to all for the importation of unsafe prescription drugs. H.R. 1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, the Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 3293, Labor, HHS Appropriations Act. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H. Con. Res. 191, Continuing Resolution. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 3200/S. 1679, Senate Finance Committee bill. Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1427/S. 726, Promoting Innovation and Access to Life-Saving Medicines Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. H.R. 3974, Viral Hepatitis & Liver Cancer Control & Prevention Act. Lobbied for passage of legislation.

H. Con. Res. 191, Continuing Resolution. Lobbied to ensure safety and access to prescription drugs. H.R. 3293, Labor Health and Human Services Appropriations bill. Lobbied to ensure safety and access to prescription drugs. H.R. 3962, Affordable Health Care for America Act and H.R. 3590, Patient Protection & Affordable Care Act (Senate). Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1548 and 1427/S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232, and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to all for the importation of unsafe prescription drugs. H.R. 1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, the Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 3293, Labor, HHS Appropriations Act. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H. Con. Res. 191, Continuing Resolution. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 3200/S. 1679, Senate Finance Committee bill. Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1427/S. 726, Promoting Innovation and Access to Life-Saving Medicines Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. H.R. 3974, Viral Hepatitis & Liver Cancer Control & Prevention Act. Lobbied for passage of legislation.

H. CON. RES 191, Continuing Resolution. Lobbied to ensure safety and access to prescription drugs. H.R. 3293, Labor Health and Human Services Appropriations bill. Lobbied to ensure safety and access to prescription drugs. NO BILL, Health Care Reform. Lobbied to gather information on potential legislation to improve the health care system and increase access to prescription drugs. H.R. 1548 and 1427/ S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232 and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R.1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, the Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 3293, Labor, HHS Appropriations Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H. Con. Res 191, Continuing Resolution. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied to ensure safety and access to prescription drugs H.R. 1298/ S. 525/ S.1232, Pharmaceutical Market Access and Drug Safety Act of 2009. Lobbied to ensure safety and access to prescription drugs. Affordable Health Choices Act. Lobbied to ensure safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied to ensure safety and access to prescription drugs. H.R. 3200/ S.1679/, Senate Finance Committee bill. Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1427/ S. 726, Promoting Innovation and Access to Life-Saving Medicine Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety and data exclusivity.

NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D. H.R. 1616, Early Treatment of HIV/AIDS. Lobbied members of Congress in support of early treatment of HIV/AIDS. H.R. 684 and S. 330, Medicare Prescription Drug Savings and Choice Act. Lobbied against establishing a government sponsored fall-back plan in Medicare Part D. H.R. 574 and S. 254, Medicare Home Infusion Therapy Coverage Act.Lobbied for passage of the bill. H.R.1458/ S.565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007. Lobbied for passage of bills. S. 301, Physician Payments Sunshine Act of 2009. Lobbied to ensure access to prescription drugs. S. 547, Drug Rebate Equalization Act. Lobbied against extending the Medicaid rebate to managed care organizations.

NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D. H.R. 1458/S. 565, Comprehensive Immunosuppresive Drug Coverage for Kidney Transplant Patients Act of 2007. Lobbied for passage of bills. S. 547, Drug Rebate Equalization Act of 2009. Lobbied against extending the Medicaid rebate to managed care organizations. H.R. 684/S. 330, Medicare Prescription Drug Savings and Choice Act of 2009. Lobbied against establishing a government sponsored fall-back plan in Medicare Part D. H.R. 574/S. 254, Medicare Home Infusion Therapy Coverage Act of 2009. Lobbied for passage of bills. S. 301, Physician Payments Sunshine Act of 2009. Lobbied to ensure access to prescription drugs. H.R. 1616, Early Treatment of HIV/AIDS. Lobbied in support of early treatment of HIV/AIDS.

NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D. H.R. 1458/S. 565, Comprehensive Immunosuppresive Drug Coverage for Kidney Transplant Patients Act of 2007. Lobbied for passage of bills. S. 547, Drug Rebate Equalization Act of 2009. Lobbied against extending the Medicaid rebate to managed care organizations. H.R. 684/S. 330, Medicare Prescription Drug Savings and Choice Act of 2009. Lobbied against establishing a government sponsored fall-back plan in Medicare Part D. H.R. 574/S. 254, Medicare Home Infusion Therapy Coverage Act of 2009. Lobbied for passage of bills. S. 301, Physician Payments Sunshine Act of 2009. Lobbied to ensure access to prescription drugs. H.R. 1616, Early Treatment of HIV/AIDS. Lobbied in support of early treatment of HIV/AIDS.

NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D. H.R.1458/ S.565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007.Lobbied for passage of bills. S. 547, Drug Rebate Equalization Act of 2009. Lobbied against extending the Medicaid rebate to managed care organizations H.R.1458/ S.565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007. Lobbied for passage of bills. H.R. 684/ S. 330, Medicare Prescription Drug Savings and Choice Act of 2009. Lobbied against establishing a government sponsored fall-back plan in Medicare Part D. H.R. 574/ S. 254, Medicare Home Infusion Therapy Coverage Act of 2009. Lobbied for passage of bills. S. 301, Physician Payments Sunshine Act of 2009. Lobbied to ensure access to prescription drugs. NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D. H.R. 1616, Early Treatment of HIV/AIDS. Lobbied in support of early treatment of HIV/AIDS.

NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D. H.R. 1616, Early Treatment of HIV/AIDS. Lobbied members of Congress in support of early treatment of HIV/AIDS. H.R. 684 and S. 330, Medicare Prescription Drug Savings and Choice Act. Lobbied against establishing a government sponsored fall-back plan in Medicare Part D. H.R. 574 and S. 254, Medicare Home Infusion Therapy Coverage Act.Lobbied for passage of the bill. H.R.1458/ S.565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007. Lobbied for passage of bills. S. 301, Physician Payments Sunshine Act of 2009. Lobbied to ensure access to prescription drugs. S. 547, Drug Rebate Equalization Act. Lobbied against extending the Medicaid rebate to managed care organizations.

NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D. H.R. 1458/S. 565, Comprehensive Immunosuppresive Drug Coverage for Kidney Transplant Patients Act of 2007. Lobbied for passage of bills. S. 547, Drug Rebate Equalization Act of 2009. Lobbied against extending the Medicaid rebate to managed care organizations. H.R. 684/S. 330, Medicare Prescription Drug Savings and Choice Act of 2009. Lobbied against establishing a government sponsored fall-back plan in Medicare Part D. H.R. 574/S. 254, Medicare Home Infusion Therapy Coverage Act of 2009. Lobbied for passage of bills. S. 301, Physician Payments Sunshine Act of 2009. Lobbied to ensure access to prescription drugs. H.R. 1616, Early Treatment of HIV/AIDS. Lobbied in support of early treatment of HIV/AIDS.

NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D. H.R. 1458/S. 565, Comprehensive Immunosuppresive Drug Coverage for Kidney Transplant Patients Act of 2007. Lobbied for passage of bills. S. 547, Drug Rebate Equalization Act of 2009. Lobbied against extending the Medicaid rebate to managed care organizations. H.R. 684/S. 330, Medicare Prescription Drug Savings and Choice Act of 2009. Lobbied against establishing a government sponsored fall-back plan in Medicare Part D. H.R. 574/S. 254, Medicare Home Infusion Therapy Coverage Act of 2009. Lobbied for passage of bills. S. 301, Physician Payments Sunshine Act of 2009. Lobbied to ensure access to prescription drugs. H.R. 1616, Early Treatment of HIV/AIDS. Lobbied in support of early treatment of HIV/AIDS.

NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D. H.R.1458/ S.565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007.Lobbied for passage of bills. S. 547, Drug Rebate Equalization Act of 2009. Lobbied against extending the Medicaid rebate to managed care organizations H.R.1458/ S.565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007. Lobbied for passage of bills. H.R. 684/ S. 330, Medicare Prescription Drug Savings and Choice Act of 2009. Lobbied against establishing a government sponsored fall-back plan in Medicare Part D. H.R. 574/ S. 254, Medicare Home Infusion Therapy Coverage Act of 2009. Lobbied for passage of bills. S. 301, Physician Payments Sunshine Act of 2009. Lobbied to ensure access to prescription drugs. NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D. H.R. 1616, Early Treatment of HIV/AIDS. Lobbied in support of early treatment of HIV/AIDS.

NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D. H.R. 1458/S. 565, Comprehensive Immunosuppresive Drug Coverage for Kidney Transplant Patients Act of 2007. Lobbied for passage of bills. S. 547, Drug Rebate Equalization Act of 2009. Lobbied against extending the Medicaid rebate to managed care organizations. H.R. 684/S. 330, Medicare Prescription Drug Savings and Choice Act of 2009. Lobbied against establishing a government sponsored fall-back plan in Medicare Part D. H.R. 574/S. 254, Medicare Home Infusion Therapy Coverage Act of 2009. Lobbied for passage of bills. S. 301, Physician Payments Sunshine Act of 2009. Lobbied to ensure access to prescription drugs. H.R. 1616, Early Treatment of HIV/AIDS. Lobbied in support of early treatment of HIV/AIDS.

NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D. H.R. 1458/S. 565, Comprehensive Immunosuppresive Drug Coverage for Kidney Transplant Patients Act of 2007. Lobbied for passage of bills. S. 547, Drug Rebate Equalization Act of 2009. Lobbied against extending the Medicaid rebate to managed care organizations. H.R. 684/S. 330, Medicare Prescription Drug Savings and Choice Act of 2009. Lobbied against establishing a government sponsored fall-back plan in Medicare Part D. H.R. 574/S. 254, Medicare Home Infusion Therapy Coverage Act of 2009. Lobbied for passage of bills. S. 301, Physician Payments Sunshine Act of 2009. Lobbied to ensure access to prescription drugs. H.R. 1616, Early Treatment of HIV/AIDS. Lobbied in support of early treatment of HIV/AIDS.

NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D. H.R.1458/ S.565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007.Lobbied for passage of bills. S. 547, Drug Rebate Equalization Act of 2009. Lobbied against extending the Medicaid rebate to managed care organizations H.R.1458/ S.565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007. Lobbied for passage of bills. H.R. 684/ S. 330, Medicare Prescription Drug Savings and Choice Act of 2009. Lobbied against establishing a government sponsored fall-back plan in Medicare Part D. H.R. 574/ S. 254, Medicare Home Infusion Therapy Coverage Act of 2009. Lobbied for passage of bills. S. 301, Physician Payments Sunshine Act of 2009. Lobbied to ensure access to prescription drugs. NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D. H.R. 1616, Early Treatment of HIV/AIDS. Lobbied in support of early treatment of HIV/AIDS.

NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D. H.R. 1616, Early Treatment of HIV/AIDS. Lobbied members of Congress in support of early treatment of HIV/AIDS. H.R. 684 and S. 330, Medicare Prescription Drug Savings and Choice Act. Lobbied against establishing a government sponsored fall-back plan in Medicare Part D. H.R. 574 and S. 254, Medicare Home Infusion Therapy Coverage Act.Lobbied for passage of the bill. H.R.1458/ S.565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007. Lobbied for passage of bills. S. 301, Physician Payments Sunshine Act of 2009. Lobbied to ensure access to prescription drugs. S. 547, Drug Rebate Equalization Act. Lobbied against extending the Medicaid rebate to managed care organizations.

H. Con. Res. 191, Continuing Resolution. Lobbied to ensure safety and access to prescription drugs. H.R. 3293, Labor Health and Human Services Appropriations bill. Lobbied to ensure safety and access to prescription drugs. H.R. 3962, Affordable Health Care for America Act and H.R. 3590, Patient Protection & Affordable Care Act (Senate). Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1548 and 1427/S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232, and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to all for the importation of unsafe prescription drugs. H.R. 1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, the Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 3293, Labor, HHS Appropriations Act. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H. Con. Res. 191, Continuing Resolution. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 3200/S. 1679, Senate Finance Committee bill. Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1427/S. 726, Promoting Innovation and Access to Life-Saving Medicines Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. H.R. 3974, Viral Hepatitis & Liver Cancer Control & Prevention Act. Lobbied for passage of legislation.

NO BILL, Health Care Reform. Lobbied to gather information on potential legislation to improve the health care system and increase access to prescription drugs. H.R.1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1548, Pathway for Biosimilars Act. Lobbied Members of congress in support of an FDA pathway for biosimilar products, patient safety and data exclusivity. H.R.1427/ S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232 and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied to ensure safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied to ensure safety and access to prescription drugs. HELP Health Reform Draft Bill. Lobbied Members of Congress to ensure safety and access to prescription drugs. Comprehensive Health Reform Draft Bill. Lobbied Members of Congress to ensure safety and access to prescription drugs. Affordable Health Choices Act. Lobbied to ensure safety and access to prescription drugs.

H. CON. RES 191, Continuing Resolution. Lobbied to ensure safety and access to prescription drugs. H.R. 3293, Labor Health and Human Services Appropriations bill. Lobbied to ensure safety and access to prescription drugs. NO BILL, Health Care Reform. Lobbied to gather information on potential legislation to improve the health care system and increase access to prescription drugs. H.R. 1548 and 1427/ S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232 and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R.1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, the Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 3293, Labor, HHS Appropriations Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H. Con. Res 191, Continuing Resolution. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied to ensure safety and access to prescription drugs H.R. 1298/ S. 525/ S.1232, Pharmaceutical Market Access and Drug Safety Act of 2009. Lobbied to ensure safety and access to prescription drugs. Affordable Health Choices Act. Lobbied to ensure safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied to ensure safety and access to prescription drugs. H.R. 3200/ S.1679/, Senate Finance Committee bill. Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1427/ S. 726, Promoting Innovation and Access to Life-Saving Medicine Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety and data exclusivity.

H. Con. Res. 191, Continuing Resolution. Lobbied to ensure safety and access to prescription drugs. H.R. 3293, Labor Health and Human Services Appropriations bill. Lobbied to ensure safety and access to prescription drugs. H.R. 3962, Affordable Health Care for America Act and H.R. 3590, Patient Protection & Affordable Care Act (Senate). Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1548 and 1427/S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232, and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to all for the importation of unsafe prescription drugs. H.R. 1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, the Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 3293, Labor, HHS Appropriations Act. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H. Con. Res. 191, Continuing Resolution. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 3200/S. 1679, Senate Finance Committee bill. Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1427/S. 726, Promoting Innovation and Access to Life-Saving Medicines Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. H.R. 3974, Viral Hepatitis & Liver Cancer Control & Prevention Act. Lobbied for passage of legislation.

NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D. H.R. 1458/S. 565, Comprehensive Immunosuppresive Drug Coverage for Kidney Transplant Patients Act of 2007. Lobbied for passage of bills. S. 547, Drug Rebate Equalization Act of 2009. Lobbied against extending the Medicaid rebate to managed care organizations. H.R. 684/S. 330, Medicare Prescription Drug Savings and Choice Act of 2009. Lobbied against establishing a government sponsored fall-back plan in Medicare Part D. H.R. 574/S. 254, Medicare Home Infusion Therapy Coverage Act of 2009. Lobbied for passage of bills. S. 301, Physician Payments Sunshine Act of 2009. Lobbied to ensure access to prescription drugs. H.R. 1616, Early Treatment of HIV/AIDS. Lobbied in support of early treatment of HIV/AIDS.

NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D. H.R. 1458/S. 565, Comprehensive Immunosuppresive Drug Coverage for Kidney Transplant Patients Act of 2007. Lobbied for passage of bills. S. 547, Drug Rebate Equalization Act of 2009. Lobbied against extending the Medicaid rebate to managed care organizations. H.R. 684/S. 330, Medicare Prescription Drug Savings and Choice Act of 2009. Lobbied against establishing a government sponsored fall-back plan in Medicare Part D. H.R. 574/S. 254, Medicare Home Infusion Therapy Coverage Act of 2009. Lobbied for passage of bills. S. 301, Physician Payments Sunshine Act of 2009. Lobbied to ensure access to prescription drugs. H.R. 1616, Early Treatment of HIV/AIDS. Lobbied in support of early treatment of HIV/AIDS.

NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D. H.R.1458/ S.565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007.Lobbied for passage of bills. S. 547, Drug Rebate Equalization Act of 2009. Lobbied against extending the Medicaid rebate to managed care organizations H.R.1458/ S.565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007. Lobbied for passage of bills. H.R. 684/ S. 330, Medicare Prescription Drug Savings and Choice Act of 2009. Lobbied against establishing a government sponsored fall-back plan in Medicare Part D. H.R. 574/ S. 254, Medicare Home Infusion Therapy Coverage Act of 2009. Lobbied for passage of bills. S. 301, Physician Payments Sunshine Act of 2009. Lobbied to ensure access to prescription drugs. NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D. H.R. 1616, Early Treatment of HIV/AIDS. Lobbied in support of early treatment of HIV/AIDS.

NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D. H.R. 1616, Early Treatment of HIV/AIDS. Lobbied members of Congress in support of early treatment of HIV/AIDS. H.R. 684 and S. 330, Medicare Prescription Drug Savings and Choice Act. Lobbied against establishing a government sponsored fall-back plan in Medicare Part D. H.R. 574 and S. 254, Medicare Home Infusion Therapy Coverage Act.Lobbied for passage of the bill. H.R.1458/ S.565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007. Lobbied for passage of bills. S. 301, Physician Payments Sunshine Act of 2009. Lobbied to ensure access to prescription drugs. S. 547, Drug Rebate Equalization Act. Lobbied against extending the Medicaid rebate to managed care organizations.

NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D. H.R.1458/ S.565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007.Lobbied for passage of bills. S. 547, Drug Rebate Equalization Act of 2009. Lobbied against extending the Medicaid rebate to managed care organizations H.R.1458/ S.565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007. Lobbied for passage of bills. H.R. 684/ S. 330, Medicare Prescription Drug Savings and Choice Act of 2009. Lobbied against establishing a government sponsored fall-back plan in Medicare Part D. H.R. 574/ S. 254, Medicare Home Infusion Therapy Coverage Act of 2009. Lobbied for passage of bills. S. 301, Physician Payments Sunshine Act of 2009. Lobbied to ensure access to prescription drugs. NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D. H.R. 1616, Early Treatment of HIV/AIDS. Lobbied in support of early treatment of HIV/AIDS.

NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D. H.R. 1458/S. 565, Comprehensive Immunosuppresive Drug Coverage for Kidney Transplant Patients Act of 2007. Lobbied for passage of bills. S. 547, Drug Rebate Equalization Act of 2009. Lobbied against extending the Medicaid rebate to managed care organizations. H.R. 684/S. 330, Medicare Prescription Drug Savings and Choice Act of 2009. Lobbied against establishing a government sponsored fall-back plan in Medicare Part D. H.R. 574/S. 254, Medicare Home Infusion Therapy Coverage Act of 2009. Lobbied for passage of bills. S. 301, Physician Payments Sunshine Act of 2009. Lobbied to ensure access to prescription drugs. H.R. 1616, Early Treatment of HIV/AIDS. Lobbied in support of early treatment of HIV/AIDS.

NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D. H.R. 1458/S. 565, Comprehensive Immunosuppresive Drug Coverage for Kidney Transplant Patients Act of 2007. Lobbied for passage of bills. S. 547, Drug Rebate Equalization Act of 2009. Lobbied against extending the Medicaid rebate to managed care organizations. H.R. 684/S. 330, Medicare Prescription Drug Savings and Choice Act of 2009. Lobbied against establishing a government sponsored fall-back plan in Medicare Part D. H.R. 574/S. 254, Medicare Home Infusion Therapy Coverage Act of 2009. Lobbied for passage of bills. S. 301, Physician Payments Sunshine Act of 2009. Lobbied to ensure access to prescription drugs. H.R. 1616, Early Treatment of HIV/AIDS. Lobbied in support of early treatment of HIV/AIDS.

H. CON. RES 191, Continuing Resolution. Lobbied to ensure safety and access to prescription drugs. H.R. 3293, Labor Health and Human Services Appropriations bill. Lobbied to ensure safety and access to prescription drugs. NO BILL, Health Care Reform. Lobbied to gather information on potential legislation to improve the health care system and increase access to prescription drugs. H.R. 1548 and 1427/ S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232 and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R.1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, the Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 3293, Labor, HHS Appropriations Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H. Con. Res 191, Continuing Resolution. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied to ensure safety and access to prescription drugs H.R. 1298/ S. 525/ S.1232, Pharmaceutical Market Access and Drug Safety Act of 2009. Lobbied to ensure safety and access to prescription drugs. Affordable Health Choices Act. Lobbied to ensure safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied to ensure safety and access to prescription drugs. H.R. 3200/ S.1679/, Senate Finance Committee bill. Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1427/ S. 726, Promoting Innovation and Access to Life-Saving Medicine Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety and data exclusivity.

NO BILL, Health Care Reform. Lobbied to gather information on potential legislation to improve the health care system and increase access to prescription drugs. H.R.1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1548, Pathway for Biosimilars Act. Lobbied Members of congress in support of an FDA pathway for biosimilar products, patient safety and data exclusivity. H.R.1427/ S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232 and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied to ensure safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied to ensure safety and access to prescription drugs. HELP Health Reform Draft Bill. Lobbied Members of Congress to ensure safety and access to prescription drugs. Comprehensive Health Reform Draft Bill. Lobbied Members of Congress to ensure safety and access to prescription drugs. Affordable Health Choices Act. Lobbied to ensure safety and access to prescription drugs.

H. Con. Res. 191, Continuing Resolution. Lobbied to ensure safety and access to prescription drugs. H.R. 3293, Labor Health and Human Services Appropriations bill. Lobbied to ensure safety and access to prescription drugs. H.R. 3962, Affordable Health Care for America Act and H.R. 3590, Patient Protection & Affordable Care Act (Senate). Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1548 and 1427/S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232, and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to all for the importation of unsafe prescription drugs. H.R. 1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, the Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 3293, Labor, HHS Appropriations Act. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H. Con. Res. 191, Continuing Resolution. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 3200/S. 1679, Senate Finance Committee bill. Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1427/S. 726, Promoting Innovation and Access to Life-Saving Medicines Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. H.R. 3974, Viral Hepatitis & Liver Cancer Control & Prevention Act. Lobbied for passage of legislation.

H. Con. Res. 191, Continuing Resolution. Lobbied to ensure safety and access to prescription drugs. H.R. 3293, Labor Health and Human Services Appropriations bill. Lobbied to ensure safety and access to prescription drugs. H.R. 3962, Affordable Health Care for America Act and H.R. 3590, Patient Protection & Affordable Care Act (Senate). Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1548 and 1427/S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232, and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to all for the importation of unsafe prescription drugs. H.R. 1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, the Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 3293, Labor, HHS Appropriations Act. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H. Con. Res. 191, Continuing Resolution. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 3200/S. 1679, Senate Finance Committee bill. Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1427/S. 726, Promoting Innovation and Access to Life-Saving Medicines Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. H.R. 3974, Viral Hepatitis & Liver Cancer Control & Prevention Act. Lobbied for passage of legislation.

H. Con. Res. 191, Continuing Resolution. Lobbied to ensure safety and access to prescription drugs. H.R. 3293, Labor Health and Human Services Appropriations bill. Lobbied to ensure safety and access to prescription drugs. H.R. 3962, Affordable Health Care for America Act and H.R. 3590, Patient Protection & Affordable Care Act (Senate). Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1548 and 1427/S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232, and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to all for the importation of unsafe prescription drugs. H.R. 1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, the Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 3293, Labor, HHS Appropriations Act. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H. Con. Res. 191, Continuing Resolution. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 3200/S. 1679, Senate Finance Committee bill. Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1427/S. 726, Promoting Innovation and Access to Life-Saving Medicines Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. H.R. 3974, Viral Hepatitis & Liver Cancer Control & Prevention Act. Lobbied for passage of legislation.

H. CON. RES 191, Continuing Resolution. Lobbied to ensure safety and access to prescription drugs. H.R. 3293, Labor Health and Human Services Appropriations bill. Lobbied to ensure safety and access to prescription drugs. NO BILL, Health Care Reform. Lobbied to gather information on potential legislation to improve the health care system and increase access to prescription drugs. H.R. 1548 and 1427/ S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232 and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R.1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, the Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 3293, Labor, HHS Appropriations Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H. Con. Res 191, Continuing Resolution. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied to ensure safety and access to prescription drugs H.R. 1298/ S. 525/ S.1232, Pharmaceutical Market Access and Drug Safety Act of 2009. Lobbied to ensure safety and access to prescription drugs. Affordable Health Choices Act. Lobbied to ensure safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied to ensure safety and access to prescription drugs. H.R. 3200/ S.1679/, Senate Finance Committee bill. Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1427/ S. 726, Promoting Innovation and Access to Life-Saving Medicine Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety and data exclusivity.

NO BILL, Health Care Reform. Lobbied to gather information on potential legislation to improve the health care system and increase access to prescription drugs. H.R.1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1548, Pathway for Biosimilars Act. Lobbied Members of congress in support of an FDA pathway for biosimilar products, patient safety and data exclusivity. H.R.1427/ S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232 and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied to ensure safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied to ensure safety and access to prescription drugs. HELP Health Reform Draft Bill. Lobbied Members of Congress to ensure safety and access to prescription drugs. Comprehensive Health Reform Draft Bill. Lobbied Members of Congress to ensure safety and access to prescription drugs. Affordable Health Choices Act. Lobbied to ensure safety and access to prescription drugs.

H. Con. Res. 191, Continuing Resolution. Lobbied to ensure safety and access to prescription drugs. H.R. 3293, Labor Health and Human Services Appropriations bill. Lobbied to ensure safety and access to prescription drugs. H.R. 3962, Affordable Health Care for America Act and H.R. 3590, Patient Protection & Affordable Care Act (Senate). Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1548 and 1427/S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232, and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to all for the importation of unsafe prescription drugs. H.R. 1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, the Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 3293, Labor, HHS Appropriations Act. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H. Con. Res. 191, Continuing Resolution. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 3200/S. 1679, Senate Finance Committee bill. Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1427/S. 726, Promoting Innovation and Access to Life-Saving Medicines Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. H.R. 3974, Viral Hepatitis & Liver Cancer Control & Prevention Act. Lobbied for passage of legislation.

NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D. H.R. 1616, Early Treatment of HIV/AIDS. Lobbied members of Congress in support of early treatment of HIV/AIDS. H.R. 684 and S. 330, Medicare Prescription Drug Savings and Choice Act. Lobbied against establishing a government sponsored fall-back plan in Medicare Part D. H.R. 574 and S. 254, Medicare Home Infusion Therapy Coverage Act.Lobbied for passage of the bill. H.R.1458/ S.565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007. Lobbied for passage of bills. S. 301, Physician Payments Sunshine Act of 2009. Lobbied to ensure access to prescription drugs. S. 547, Drug Rebate Equalization Act. Lobbied against extending the Medicaid rebate to managed care organizations.

NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D. H.R.1458/ S.565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007.Lobbied for passage of bills. S. 547, Drug Rebate Equalization Act of 2009. Lobbied against extending the Medicaid rebate to managed care organizations H.R.1458/ S.565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007. Lobbied for passage of bills. H.R. 684/ S. 330, Medicare Prescription Drug Savings and Choice Act of 2009. Lobbied against establishing a government sponsored fall-back plan in Medicare Part D. H.R. 574/ S. 254, Medicare Home Infusion Therapy Coverage Act of 2009. Lobbied for passage of bills. S. 301, Physician Payments Sunshine Act of 2009. Lobbied to ensure access to prescription drugs. NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D. H.R. 1616, Early Treatment of HIV/AIDS. Lobbied in support of early treatment of HIV/AIDS.

H. Con. Res. 191, Continuing Resolution. Lobbied to ensure safety and access to prescription drugs. H.R. 3293, Labor Health and Human Services Appropriations bill. Lobbied to ensure safety and access to prescription drugs. H.R. 3962, Affordable Health Care for America Act and H.R. 3590, Patient Protection & Affordable Care Act (Senate). Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1548 and 1427/S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232, and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to all for the importation of unsafe prescription drugs. H.R. 1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, the Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 3293, Labor, HHS Appropriations Act. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H. Con. Res. 191, Continuing Resolution. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 3200/S. 1679, Senate Finance Committee bill. Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1427/S. 726, Promoting Innovation and Access to Life-Saving Medicines Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. H.R. 3974, Viral Hepatitis & Liver Cancer Control & Prevention Act. Lobbied for passage of legislation.

H. Con. Res. 191, Continuing Resolution. Lobbied to ensure safety and access to prescription drugs. H.R. 3293, Labor Health and Human Services Appropriations bill. Lobbied to ensure safety and access to prescription drugs. H.R. 3962, Affordable Health Care for America Act and H.R. 3590, Patient Protection & Affordable Care Act (Senate). Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1548 and 1427/S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232, and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to all for the importation of unsafe prescription drugs. H.R. 1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, the Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 3293, Labor, HHS Appropriations Act. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H. Con. Res. 191, Continuing Resolution. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 3200/S. 1679, Senate Finance Committee bill. Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1427/S. 726, Promoting Innovation and Access to Life-Saving Medicines Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. H.R. 3974, Viral Hepatitis & Liver Cancer Control & Prevention Act. Lobbied for passage of legislation.

H. Con. Res. 191, Continuing Resolution. Lobbied to ensure safety and access to prescription drugs. H.R. 3293, Labor Health and Human Services Appropriations bill. Lobbied to ensure safety and access to prescription drugs. H.R. 3962, Affordable Health Care for America Act and H.R. 3590, Patient Protection & Affordable Care Act (Senate). Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1548 and 1427/S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232, and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to all for the importation of unsafe prescription drugs. H.R. 1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, the Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 3293, Labor, HHS Appropriations Act. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H. Con. Res. 191, Continuing Resolution. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 3200/S. 1679, Senate Finance Committee bill. Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1427/S. 726, Promoting Innovation and Access to Life-Saving Medicines Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. H.R. 3974, Viral Hepatitis & Liver Cancer Control & Prevention Act. Lobbied for passage of legislation.

H. Con. Res. 191, Continuing Resolution. Lobbied to ensure safety and access to prescription drugs. H.R. 3293, Labor Health and Human Services Appropriations bill. Lobbied to ensure safety and access to prescription drugs. H.R. 3962, Affordable Health Care for America Act and H.R. 3590, Patient Protection & Affordable Care Act (Senate). Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1548 and 1427/S. 726, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. S. 525, S. 1232, and H.R. 1298, Pharmaceutical Market Access and Drug Safety Act. Lobbied against passage of legislation to all for the importation of unsafe prescription drugs. H.R. 1, American Recovery and Reinvestment Act. Lobbied to include language encouraging clinical comparative effectiveness rather than cost effectiveness. H.R. 1105, making appropriations for Fiscal Year 2009. Lobbied for increased access to HIV/AIDS drugs in the Aids Drug Assistance Program. S. 982, Family Smoking Prevention and Tobacco Control Act. Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. S. 1213 and H.R. 2502, the Patient-Centered Outcomes Research Act. Lobbied Members of Congress to ensure safety and access to prescription drugs. H.R. 3293, Labor, HHS Appropriations Act. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H. Con. Res. 191, Continuing Resolution. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 759, Food and Drug Administration Globalization Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 2502, Comparative Effectiveness Research Act of 2009. Lobbied Members of Congress to ensure patient safety and access to prescription drugs. H.R. 3200/S. 1679, Senate Finance Committee bill. Lobbied to improve the health care system and increase access to prescription drugs. H.R. 1427/S. 726, Promoting Innovation and Access to Life-Saving Medicines Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. H.R. 3974, Viral Hepatitis & Liver Cancer Control & Prevention Act. Lobbied for passage of legislation.

NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D. H.R. 1616, Early Treatment of HIV/AIDS. Lobbied members of Congress in support of early treatment of HIV/AIDS. H.R. 684 and S. 330, Medicare Prescription Drug Savings and Choice Act. Lobbied against establishing a government sponsored fall-back plan in Medicare Part D. H.R. 574 and S. 254, Medicare Home Infusion Therapy Coverage Act.Lobbied for passage of the bill. H.R.1458/ S.565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007. Lobbied for passage of bills. S. 301, Physician Payments Sunshine Act of 2009. Lobbied to ensure access to prescription drugs. S. 547, Drug Rebate Equalization Act. Lobbied against extending the Medicaid rebate to managed care organizations.

NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D. H.R.1458/ S.565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007.Lobbied for passage of bills. S. 547, Drug Rebate Equalization Act of 2009. Lobbied against extending the Medicaid rebate to managed care organizations H.R.1458/ S.565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007. Lobbied for passage of bills. H.R. 684/ S. 330, Medicare Prescription Drug Savings and Choice Act of 2009. Lobbied against establishing a government sponsored fall-back plan in Medicare Part D. H.R. 574/ S. 254, Medicare Home Infusion Therapy Coverage Act of 2009. Lobbied for passage of bills. S. 301, Physician Payments Sunshine Act of 2009. Lobbied to ensure access to prescription drugs. NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D. H.R. 1616, Early Treatment of HIV/AIDS. Lobbied in support of early treatment of HIV/AIDS.